Patent · US Active

Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof

US11963947B2 · kind B2 · utility

0Cited by

2References

28Claims

0Family size

Assignee

HUA Medicine (Shanghai) Ltd. · CN

Inventors

Li Chen · Shanghai, CN
Yongguo Li · Shanghai, CN
Gaosen Wang · Shanghai, CN
Huisheng Gao · Shanghai, CN

Key dates

Filing date	May 28, 2019
Grant date	Apr 23, 2024
Priority date	—
Expiry date	Mar 24, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a pharmaceutical combination comprising a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic label thereof, a crystalline form thereof, a hydrate, a solvate, a diastereomeric or enantiomeric form thereof, and a DPP-IV inhibitor. Disclosed are a pharmaceutical composition and a fixed dose of a compound preparation, and the methods for preparing the pharmaceutical composition and the fixed dose of the compound preparation and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.